In addition, we also revealed that ADH1A was positively related to the response of fluorouracil, and LCMT1 was negatively correlated to the therapeutic effect of Lenvatinib, implying that these prognostic-related TRGs may also influence the therapeutic efficacy of HCC. This evidence concerns the gene ADH1A and hepatocellular carcinoma.